119134 Adenosine 5ʹ-O-(2-Thiodiphosphate), Trilithium Salt - CAS 73536-95-5 - Calbiochem

119134
Árak és elérhetőség megtekintése

Áttekintés

Replacement Information

Kulcsspecifikációk táblázata

CAS #
73536-95-5

Árak és elérhetőség

Katalógusszám ElérhetőségCsomagolás Menny./csomag Ár Mennyiség
119134-25MG
Elérhetőség betöltése...
Korlátozott elérhetőségKorlátozott elérhetőség
Készleten 
Megszűnt
Korlátozott mennyiségben elérhető
Az elérhetőség megerősítésre vár
    Remaining : Will advise
      Remaining : Will advise
      Tanácsadás
      Lépjen kapcsolatba a vevőszolgálattal
      Contact Customer Service

      Muanyagampulla 25 mg
      Az ár letöltése folyamatban...
      Az ár nem tölthető be
      Minimum Quantity needs to be mulitiple of
      Megrendelés befejezésekor További információ
      Elmentette a ()-t
       
      Árajánlat kérése
      Description
      OverviewA P2-purinergic receptor agonist that acts as a potent insulin secretagogue. Substrate and inhibitor of ADP-dependent enzyme systems.
      Catalogue Number119134
      Brand Family Calbiochem®
      SynonymsADP-β-S, 3Li
      References
      ReferencesShalev, M., et al. 1999. J. Urol. 161, 955.
      Hillaire-Buys, D., et al. 1993. Br. J. Pharmacol. 109, 183.
      Bertrand, G., et al. 1991. Br. J. Pharmacol. 102, 627.
      Eckstein, F., and Goody, R.S. 1976. Biochemistry 15, 1685.
      Product Information
      CAS number73536-95-5
      ATP CompetitiveN
      FormWhite solid
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetA P2-purinergic receptor agonist
      Purity≥80% by HPLC
      Physicochemical Information
      Cell permeableN
      ContaminantsADP: ≤10%
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage -20°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Adenosine 5ʹ-O-(2-Thiodiphosphate), Trilithium Salt - CAS 73536-95-5 - Calbiochem MSDS

      Title

      Safety Data Sheet (SDS) 

      Adenosine 5ʹ-O-(2-Thiodiphosphate), Trilithium Salt - CAS 73536-95-5 - Calbiochem Certificates of Analysis

      TitleLot Number
      119134

      References

      Hivatkozások áttekintése
      Shalev, M., et al. 1999. J. Urol. 161, 955.
      Hillaire-Buys, D., et al. 1993. Br. J. Pharmacol. 109, 183.
      Bertrand, G., et al. 1991. Br. J. Pharmacol. 102, 627.
      Eckstein, F., and Goody, R.S. 1976. Biochemistry 15, 1685.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision08-April-2008 RFH
      SynonymsADP-β-S, 3Li
      DescriptionSubstrate and inhibitor of ADP-dependent enzyme systems. A P2-purinergic agonist that acts as a potent insulin secretagogue.
      FormWhite solid
      CAS number73536-95-5
      Structure formulaStructure formula
      Purity≥80% by HPLC
      ContaminantsADP: ≤10%
      SolubilityH₂O (20 mg/ml)
      Storage -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesShalev, M., et al. 1999. J. Urol. 161, 955.
      Hillaire-Buys, D., et al. 1993. Br. J. Pharmacol. 109, 183.
      Bertrand, G., et al. 1991. Br. J. Pharmacol. 102, 627.
      Eckstein, F., and Goody, R.S. 1976. Biochemistry 15, 1685.